An association study of the neurotensin receptor gene with schizophrenia and clozapine response [3]

Schizophrenia Research

Volumn 66, Issue 2-3, 2004, Pages 193-195

  Huezo Diaz, P ^a   Arranz, M J ^a   Munro, J ^a   Osborne, S ^a   Makoff, A ^a   Kerwin, R W ^a   Austin, J ^b   O'Donovan, M ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; NEUROTENSIN RECEPTOR;

ALLELE; BASE PAIRING; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA FLANKING REGION; DNA POLYMORPHISM; DRUG RESPONSE; GENE; GENE FREQUENCY; GENERAL CONDITION IMPROVEMENT; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0346100525     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(03)00128-2     Document Type: Letter

References (12)

1. Austin J., Buckland P., Cardno A.G., Williams N., Spurlock G., Hoogendoorn B., Zammit S., Jones G., Sanders R., Jones L., McCarthy G., Jones S., Bray N.J., McGuffin P., Owen M.J., O'donovan M.C. The high affinity neurotensin receptor gene (NTSR1): comparative sequencing and association studies in schizophrenia. Mol. Psychiatry. 5(5):2000;552-557.
2. Binder E.B., Kinkead B., Owens M.J., Nemeroff C.B. The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugs. Biol. Psychiatry. 50(11):2001;856-872.
3. Endicott J., Spitzer R.L., Fleiss J.L., Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch. Gen. Psychiatry. 33(6):1976;766-771.
4. Gruber S.H., Nomikos G.G., Mathe A.A. Effects of haloperidol and risperidone on neurotensin levels in brain regions and neurotensin efflux in the ventral striatum of the rat. Neuropsychopharmacology. 26(5):2002;595-604.
5. Hamid E.H., Hyde T.M., Egan M.F., Wolf S.S., Herman M.M., Nemeroff C.B., Kleinman J.E. Neurotensin receptor binding abnormalities in the entorhinal cortex in schizophrenia and affective disorders. Biol. Psychiatry. 51(10):2002;795-800.
6. Kashi Y., King D., Soller M. Simple sequence repeats as a source of quantitative genetic variation. Trends Genet. 13(2):1997;74-78.
7. Le F., Groshan K., Zeng X.P., Richelson E. Characterization of the genomic structure, promoter region, and a tetranucleotide repeat polymorphism of the human neurotensin receptor gene. J. Biol. Chem. 272(2):1997;1315-1322.
8. Lee Y.S., Han J.H., Kim H.B., Lee J.S., Joo Y.H., Yang B.H. An association study of neurotensin receptor gene polymorphism with schizophrenia. Schizophr. Res. 36(1-3):1999;92.
9. Pettibone D.J., Hess J.F., Hey P.J., Jacobson M.A., Leviten M., Lis E.V., Mallorga P.J., Pascarella D.M., Snyder M.A., Williams J.B., Zeng Z. The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin. J. Pharmacol. Exp. Ther. 300(1):2002;305-313.
10. Sham P.C., Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann. Hum. Genet. 59(Pt. 1):1995;97-105.
11. Xie X., Ott J. Testing linkage disequilibrium between a disease gene and marker loci. Am. J. Hum. Genet. 53:1993;1107.
12. Zhao J.H., Curtis D., Sham P.C. Model-free analysis and permutation tests for allelic associations. Hum. Hered. 50(2):2000;133-139.